ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,375.86
1.67%
US Tech 100
18,212.00
2.43%
Dow Jones
39,606.57
1.07%
Brent Oil
65.35
-2.53%
Bitcoin
93,747.20
0.34%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Skye Bioscience Inc (SKYE) Quote

Skye Bioscience Inc

Skye Bioscience Inc (SKYE)

First Trust Cloud Computing UCITS ETF Class A Accumulation
First Trust Cloud Computing UCITS ETF Class A Accumulation
1.73
0.22
(14.57%)
At close: April 23 4:00PM
Delayed by 15 minutes
1.71
-0.02
( -1.16% )
After Hours: 7:11PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.71
Bid
1.68
Ask
1.76
Volume
446,520
1.48 Day's Range 1.73
1.14 52 Week Range 15.5994
Market Cap
52.966M
Previous Close
1.51
Open
1.55
Last Trade
614
@
1.71
(formt)
Last Trade Time
19:11:48
Financial Volume
$ 716,093
VWAP
1.6037
Average Volume (3m)
714,763
Shares Outstanding
30,974,558
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
6.24M
Net Profit
-26.57M

About Skye Bioscience Inc

Skye Bioscience a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substa... Skye Bioscience a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
skyebioscience.com
Headquarters
Carson City, Nevada, USA
Founded
-
Skye Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SKYE. The last closing price for Skye Bioscience was $1.51. Over the last year, Skye Bioscience shares have traded in a share price range of $ 1.14 to $ 15.5994.

Skye Bioscience currently has 30,974,558 shares outstanding. The market capitalization of Skye Bioscience is $46.77 million.

Ask ADVFN Intelligence (AI)

SKYE Latest News

More News

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
March 20 2025
SKYE (14.57%)

Form 8-K - Current report
Edgar (US Regulatory)
March 20 2025
SKYE (14.57%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 20 2025
SKYE (14.57%)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Edgar (US Regulatory)
February 28 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 26 2025
SKYE (14.57%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.084.907975460121.631.761.366927401.53575758CS
4-0.6-25.9740259742.313.7271.1417487881.6788465CS
12-0.94-35.47169811322.654.251.147147631.90236842CS
26-3.23-65.38461538464.945.961.144242812.30125274CS
52-13.79-88.967741935515.515.59941.143428493.73260674CS
156-11.79-87.333333333313.517.64731.143348503.82625583CS
260-11.79-87.333333333313.517.64731.143348503.82625583CS

SKYE - Frequently Asked Questions (FAQ)

What is the current Skye Bioscience share price?
The current share price of Skye Bioscience is $ 1.71
How many Skye Bioscience shares are in issue?
Skye Bioscience has 30,974,558 shares in issue
What is the market cap of Skye Bioscience?
The market capitalisation of Skye Bioscience is USD 46.77M
What is the 1 year trading range for Skye Bioscience share price?
Skye Bioscience has traded in the range of $ 1.14 to $ 15.5994 during the past year
What is the reporting currency for Skye Bioscience?
Skye Bioscience reports financial results in USD
What is the latest annual turnover for Skye Bioscience?
The latest annual turnover of Skye Bioscience is USD 6.24M
What is the latest annual profit for Skye Bioscience?
The latest annual profit of Skye Bioscience is USD -26.57M
What is the registered address of Skye Bioscience?
The registered address for Skye Bioscience is 701 S CARSON ST, STE 200, CARSON CITY, NEVADA, 89701
What is the Skye Bioscience website address?
The website address for Skye Bioscience is skyebioscience.com
Which industry sector does Skye Bioscience operate in?
Skye Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PETWag Group Company
$ 0.178
(61.38%)
30.53M
LGCBLinkage Global Inc
$ 2.70
(43.62%)
2.29M
TWGTop Wealth Group Holding Ltd
$ 0.1835
(21.85%)
19.37M
CEPCantor Equity Partners Inc
$ 19.44
(17.82%)
2.27M
CNEYCN Energy Group Inc
$ 0.149
(17.23%)
2.71M
GNLNGreenlane Holdings Inc
$ 0.0193
(-92.14%)
47.78M
CMLSCumulus Media Inc
$ 0.1968
(-27.08%)
397.18k
RLMDRelmada Therapeutics Inc
$ 0.5114
(-25.88%)
8.57M
AGMHAGM Group Holdings Inc
$ 0.0468
(-19.31%)
9.52M
ENSCEnsysce Biosciences Inc
$ 3.22
(-12.26%)
1.23M
DMNDamon Inc
$ 0.00385
(-6.10%)
59.24M
GNLNGreenlane Holdings Inc
$ 0.0193
(-92.14%)
47.78M
PETWag Group Company
$ 0.178
(61.38%)
30.53M
OCEAOcean Biomedical Inc
$ 0.0204
(-0.49%)
21.02M
TWGTop Wealth Group Holding Ltd
$ 0.1835
(21.85%)
19.37M

Discussion

View Full Feed
joe_techi joe_techi 2 minutes ago
Massive Attack - Unfinished Sympathy
https://www.youtube.com/watch?v=ZWmrfgj0MZI
dinogreeves dinogreeves 3 minutes ago
Best not pay attention to him, he has "vindictive" intentions. Do you know what says? That says he is heart broken when I had to rain on his parade with $FITY scam to the core. $FITY was an obvious scam, apparently had a deal with SpaceX and Elon (Give me a break will you), if it doesn't make s
FITY TGLO
oldoil oldoil 3 minutes ago
what's new ???
ERHE
BIOCHEMUP BIOCHEMUP 4 minutes ago
https://naturalresources.house.gov/calendar/eventsingle.aspx?EventID=417053
TMC
Value_Investor Value_Investor 4 minutes ago
WARNING To All! -$10,898,009 or $11M HUGE NEGATIVE Net Asset or Shareholder's Equity Value (see the latest financial report below) and only Mere $585 Cash on hand! Horrible Nightmare Finance here (see the link below for the details)!

https://www.otcmarkets.com/otcapi/company/fina
ALST
blackhawks blackhawks 4 minutes ago
In other words dogma is synonymous with religion. Period.

The rocks are in your head. Don't belabor me anymore with your uncomprehending posts.

And just when did you drop out of the smorgasbord line?
wamugold wamugold 5 minutes ago
I might pick up some COOP shares when it deeps below $70
COOP
WebSlinger WebSlinger 5 minutes ago
As of today, KBLB has diluted 4,594,804 shares over the past few months.

>

I have been saying that for a long time.

>

As dilut
KBLB
FOFreddie FOFreddie 6 minutes ago
Thanks for the insights CCSAB. Staying the course and hoping for the $ 20 to $ 30 range along with JPS with consensual conversion. Tik Tok and Ukraine have to be deals but will take more time. Any thoughts on legal settlements and timing - seems like this could be rolled into safety and soundn
FNMA
uber darthium uber darthium 6 minutes ago
Rontec, how much promoting this scam are you responsible for ?

Asking for some harmed shareholders looking for justice

I heard you can make me a great deal on slightly used capacitors

Have any of that electrical grade plexiglass laying around ?
ASRE
MarauderWarlock33 MarauderWarlock33 6 minutes ago
MHRA-101389-PIP01-24%20%7C%20MHRA.html

This drug just got approved by MHRA and has compliance acceptance date of 6 March 2024 a one day before DCVAX-L 7 March 2024. Maybe tomorrow ? Fingers cross!
NWBO
toddski toddski 7 minutes ago
The streamlined share structure also positions the Company to engage more effectively with long-term investors as it continues to build value through product innovation and data-driven execution. This means.....they don't want penny flippers buying/selling the stock. They want buy and hold investors
HLLK
joe_techi joe_techi 7 minutes ago
Lets give it through July. If nothing of business substance happens can we all agree and admit this is the scam that many suspected years ago?
NPHC
Ex-brokerBry Ex-brokerBry 7 minutes ago
If there not using helium then what propels the airship up.
UMAV
wamugold wamugold 8 minutes ago
Creyno I gave up on legacy riches a long time ago! I cannot believe people still waiting after so many years, a real act of lunacy to be still talking about legacy shares. The only winner here was Brian Rosen and Proskauer Rose LLP....
COOP
janga janga 8 minutes ago
My take; no doubt a short was trying to cover and cover quietly seemed to be in a mad rush so the price is likely to bolt upwards imo
NIHK
somberfox somberfox 8 minutes ago
Be a lot cooler if we didnt at all and did a buy back. But I get it i guess.
CLNV
DesertDrifter DesertDrifter 9 minutes ago
Well put. eom
northam43 northam43 11 minutes ago
SPX Monthly Chart.

Current Cycle: M-E-2 Type Cycle: Bull Projection: 6460.75 High due: 2/28/25

Next Cycles: M-S-1, Bear, due 12/14/25, projection 5378.24 (reached), projected confirmation 4/30/25, low due: 4/30/25, then M-S-2, Bull, due 9/26/26, projection
dragoon76 dragoon76 11 minutes ago
I don't ever remember seeing the CEO of an acquired company become the CEO of the acquiring company, immediately after the acquisition is completed.
That's just strange to me.
COOP
leverage102 leverage102 12 minutes ago
143,000 VIEWS $$$. https://investorshub.advfn.com/boards/most_read.aspx?_gl=1*q74zut*_gcl_au*MjQ4MjQ5NTguMTc0NDIyOTU4MA..
VGTL
StockInfo11 StockInfo11 12 minutes ago
Black Swan Graphene (SWAN.v BSWGF) is driving industrial adoption of graphene in plastics & concrete. Its GEM™ pellets boost plastic strength by 30% & cut weight by 25%. For concrete, similar strength can be achieved with ~40% less material. SWAN has 16+ patents & an upcoming global rollout. More⬇️
BSWGF
Goldenboy17 Goldenboy17 13 minutes ago
Though I've been labeled an affiliate via no evidence by a non-shareholder (typical), I won't be attending.

Or will I????

LOL!

But if I hear anything from the event, I'll pass it along.

An investor event last year drove the price to 3 cent
SFRX

Your Recent History

NASDAQ
SKYE
Skye Bioscience
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads